NCT00116441已完成1 期
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line
Cell Genesys1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2000年10月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Multiple myeloma
研究概览
简要总结
The purpose of this study is to evaluate the safety and efficacy of vaccination with autologous myeloma cells and an allogeneic granulocyte-macrophage colony stimulating factor (GM-CSF) producing cell line.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •De novo multiple myeloma
- •No serious co-morbid illnesses and adequate organ function
- •> 4 weeks from systemic steroids
排除标准
- •No existing secondary malignancies and no history of secondary malignancies in the past 5 years
- •No active autoimmune disease
结局指标
主要结局
Multiple myeloma
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous LeukemiaAcute Myelogenous LeukemiaNCT00116467Cell Genesys55
撤回
不适用
The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic NeuropathyDiabetic NeuropathyNCT02315235Seoul National University Hospital
Unknown
1 期
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb IschemiaLeg UlcerDiabetic FootIschemiaGangrenePeripheral Vascular DiseaseNCT02993809South China Research Center for Stem Cell and Regenerative Medicine40
已完成
1 期
Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in ChildrenTraumatic Brain InjuryNCT00254722The University of Texas Health Science Center, Houston10
已完成
1 期
Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationChronic Lymphocytic LeukemiaNCT00442130Dana-Farber Cancer Institute27